Infarmed to Link Obesity Drug Reimbursement to New Evaluation System

Infarmed, the Portuguese health authority, announced that reimbursement for obesity medications will now be contingent on a new evaluation system (Sinats), which includes reinforced risk-sharing models and periodic contract reviews to ensure clinical and economic value.

Post Share

Sources

Showing 0 of 1 sources

No articles available in your preferred languages.

1 article available in other languages below.

publicoPortuguese113d ago

Infarmed: comparticipação dos medicamentos para a obesidade só com novo sistema de avaliação

Novo Sinats prevê o reforço dos modelos de partilha de risco e a revisão periódica de contratos, de modo a garantir que o SNS paga pelas tecnologias apenas quando têm valor clínico e económico.

Read full article →

Infarmed to Link Obesity Drug Reimbursement to New Evaluation System

Sources

Infarmed: comparticipação dos medicamentos para a obesidade só com novo sistema de avaliação

Related Stories

WHO Warns of Critical Shortages as Ebola Outbreak Spreads Across Democratic Republic of Congo

Pamela Anderson Recalls Overcoming a Fatal Hepatitis C Diagnosis

Private Health Insurance Coverage Expands Across Austria

Study Finds Secondhand Smoke Caused Nearly 1.7 Million Deaths Globally